Related Experiment Video
Updated: Aug 14, 2026
13:45
Real-time Imaging of Leukotriene B4 Mediated Cell Migration and BLT1 Interactions with β-arrestin
Published on: December 23, 2010
Leukotrienes C and D induce bronchoconstriction in man
Agents and Actions
|December 1, 1981
Summary
Synthetic leukotrienes C and D caused moderate bronchoconstriction and coughing in healthy individuals. The drug FPL 55712 effectively reduced these pulmonary responses, suggesting a potential therapeutic target.
Area of Science:
- Respiratory Medicine
- Pharmacology
Background:
- Leukotrienes are inflammatory mediators implicated in asthma.
- Synthetic leukotrienes C and D's effects on pulmonary function require further elucidation.
Purpose of the Study:
- To investigate the pulmonary responses to synthetic leukotrienes C and D in normal volunteers.
- To assess the efficacy of FPL 55712 in modulating these responses.
Main Methods:
- Two normal volunteers inhaled aerosols of synthetic leukotrienes C and D.
- Pulmonary function parameters, including FEV1 and expiratory flow at low lung volumes, were measured.
- The effect of FPL 55712 on leukotriene-induced responses was evaluated.
Main Results:
- Leukotrienes C and D were equipotent and equieffective in causing moderate bronchoconstriction and coughing.
- FEV1 changes were minimal, while expiratory flow reductions were significant at low lung volumes.
- FPL 55712 completely abolished the cough reflex and partially inhibited bronchoconstriction.
Conclusions:
- Synthetic leukotrienes C and D induce significant pulmonary responses in healthy individuals.
- FPL 55712 demonstrates potential as a therapeutic agent for leukotriene-mediated respiratory effects.
Related Concept Videos
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
01:26Asthma-II: Pathophysiology and Classification
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
01:28Asthma I: Introduction
Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...